Low-dose computed tomography screening reduces lung cancer mortality.

[1]  Witold Rzyman,et al.  European position statement on lung cancer screening. , 2017, The Lancet. Oncology.

[2]  L. Ek,et al.  Implementation of lung cancer CT screening in the Nordic countries , 2017, Acta oncologica.

[3]  Sunghoon Kim,et al.  Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer , 2017, Journal of Cancer.

[4]  P. V. Van Schil,et al.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  H. D. de Koning,et al.  Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada , 2017, PLoS medicine.

[6]  G. Bronte,et al.  Semi-automated volumetric analysis in the NELSON trial for lung cancer screening: is there room for diagnostic experience yet? , 2016, Journal of thoracic disease.

[7]  R. Dziadziuszko,et al.  Serum mass profile signature as a biomarker of early lung cancer. , 2016, Lung cancer.

[8]  H. Ashraf,et al.  Implementation and organization of lung cancer screening. , 2016, Annals of translational medicine.

[9]  P. V. van Ooijen,et al.  Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. , 2016, The Lancet. Oncology.

[10]  John K Field,et al.  The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. , 2016, Health technology assessment.

[11]  C. Henschke,et al.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms. , 2016, Annals of translational medicine.

[12]  M. Adamek,et al.  Risk factors assessment and risk prediction models in lung cancer screening candidates. , 2016, Annals of translational medicine.

[13]  B. Pyenson,et al.  2016 reflections on the favorable cost-benefit of lung cancer screening. , 2016, Annals of translational medicine.

[14]  D. Midthun,et al.  Early detection of lung cancer , 2016, F1000Research.

[15]  J. Mulshine,et al.  Lung cancer screening moving forward. , 2016, Annals of translational medicine.

[16]  P. Massion,et al.  Biomarkers of risk to develop lung cancer in the new screening era. , 2016, Annals of translational medicine.

[17]  J. Zulueta,et al.  Lung cancer screening in patients with chronic obstructive pulmonary disease. , 2016, Annals of translational medicine.

[18]  Marta Mańczuk,et al.  Lung cancer epidemiology: contemporary and future challenges worldwide. , 2016, Annals of translational medicine.

[19]  Joseph Shemesh,et al.  Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT? , 2016, Annals of translational medicine.

[20]  D. Ettinger,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[21]  C. la Vecchia,et al.  Screening with Low‐Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  K. Owzar,et al.  Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I–III Non–Small-Cell Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  C. Henschke,et al.  CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds. , 2015, Radiology.

[24]  H. Kauczor,et al.  Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  G. Gazelle,et al.  Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis , 2015, Cancer.

[26]  D. Wood,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening. , 2015, Thoracic surgery clinics.

[27]  B. Meyers,et al.  Health risks from computed tomographic screening. , 2015, Thoracic surgery clinics.

[28]  H. Kauczor,et al.  ESR/ERS white paper on lung cancer screening , 2015, European Respiratory Journal.

[29]  S. Duffy,et al.  LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence , 2015, Cancer Prevention Research.

[30]  E. Kazerooni,et al.  Performance of Lung-RADS in the National Lung Screening Trial , 2015, Annals of Internal Medicine.

[31]  Ning Wu,et al.  CT screening for lung cancer: Importance of emphysema for never smokers and smokers. , 2015, Lung cancer.

[32]  T. Zdrojewski,et al.  Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experience. , 2015, Polskie Archiwum Medycyny Wewnetrznej.

[33]  C. Gatsonis,et al.  Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial , 2014, Cancer.

[34]  O. Brawley,et al.  Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. , 2014, Oncology.

[35]  Adam Wallis,et al.  The revised lung adenocarcinoma classification-an imaging guide. , 2014, Journal of thoracic disease.

[36]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[37]  Elyse R Park,et al.  A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[38]  B. Kramer,et al.  Overdiagnosis in low-dose computed tomography screening for lung cancer. , 2014, JAMA internal medicine.

[39]  A. Dirksen,et al.  Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme , 2014, Thorax.

[40]  R. Dziedzic,et al.  Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions. , 2013, Interactive cardiovascular and thoracic surgery.

[41]  C. Berg,et al.  Screening for lung cancer with low-dose computed tomography: a review of current status. , 2013, Journal of thoracic disease.

[42]  Kyung Soo Lee,et al.  Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. , 2013, Chest.

[43]  Leslie E. Quint,et al.  Incidental, subsolid pulmonary nodules at CT: etiology and management , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[44]  G. Silvestri,et al.  Computed Tomography Screening for Lung Cancer , 2013, Annals of Internal Medicine.

[45]  H. D. de Koning,et al.  Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial , 2013, European Respiratory Journal.

[46]  M. Mascalchi,et al.  Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[47]  D. Aberle,et al.  Results of initial low-dose computed tomographic screening for lung cancer. , 2013, The New England journal of medicine.

[48]  A. Nicholson,et al.  Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. , 2013, Archives of pathology & laboratory medicine.

[49]  D. Naidich,et al.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[50]  P. Boiselle.  Computed tomography screening for lung cancer. , 2013, JAMA.

[51]  H. Groen,et al.  Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals , 2013, European Radiology.

[52]  D. Aberle,et al.  Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  M. Yoder,et al.  Development and Validation of a Plasma Biomarker Panel for Discerning Clinical Significance of Indeterminate Pulmonary Nodules , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[54]  Yingyong Hou,et al.  Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. , 2012, American journal of respiratory and critical care medicine.

[55]  A. Iwasaki,et al.  Surgical outcomes of lung cancer measuring less than 1 cm in diameter. , 2012, Interactive cardiovascular and thoracic surgery.

[56]  Heber MacMahon,et al.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. , 2012, The Journal of thoracic and cardiovascular surgery.

[57]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[58]  J. Jett,et al.  Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[59]  C. Berg,et al.  Formidable challenges ahead for lung cancer screening. , 2012, Oncology.

[60]  Dianna D. Cody,et al.  Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. , 2011, AJR. American journal of roentgenology.

[61]  D. Hansell,et al.  European and North American lung cancer screening experience and implications for pulmonary nodule management , 2011, European Radiology.

[62]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[63]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[64]  Ugo Pastorino,et al.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.

[65]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[66]  Fabien Maldonado,et al.  Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. , 2010, Chest.

[67]  R. V. van Klaveren,et al.  Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial , 2010, Thorax.

[68]  J. Leader,et al.  Association of radiographic emphysema and airflow obstruction with lung cancer. , 2008, American journal of respiratory and critical care medicine.

[69]  Harry J de Koning,et al.  Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial) , 2008, Cancer.

[70]  H. Kauczor,et al.  Radiation dose reduction in chest CT: a review. , 2008, AJR. American journal of roentgenology.

[71]  Gorka Bastarrika,et al.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. , 2007, Chest.

[72]  J. Habbema,et al.  Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON) , 2007, International journal of cancer.

[73]  M. Oudkerk,et al.  Neglectable benefit of searching for incidental findings in the Dutch--Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT , 2007, European Radiology.

[74]  O. Miettinen,et al.  Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .

[75]  J. Austin,et al.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. , 2005, Radiology.

[76]  S. Swensen,et al.  Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. , 2004, The Journal of thoracic and cardiovascular surgery.

[77]  C. Henschke,et al.  Smoking cessation following CT screening for early detection of lung cancer. , 2001, Preventive medicine.

[78]  A. Richardson.  Screening and the number needed to treat , 2001, Journal of medical screening.

[79]  J C Eggleston,et al.  Transthoracic needle aspiration biopsy of benign and malignant lung lesions. , 1985, AJR. American journal of roentgenology.

[80]  W. Rzyman,et al.  Low-dose computed-tomography lung cancer screening: the first European recommendations from the European Society of Radiology and European Respiratory Society. , 2015, Polskie Archiwum Medycyny Wewnetrznej.

[81]  P. Pauwels,et al.  Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians , 2015, The Journal of the American Board of Family Medicine.

[82]  B. Goulart.  The Value of Lung Cancer CT Screening: It Is All about Implementation. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[83]  G. Adam,et al.  The Usage of 2 and 3-Dimensionel Ultrasound in Prenatal Diagnosis of Sacrococcygeal Teratoma: Report of a Case , 2013, Annals of Clinical and Analytical Medicine.

[84]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.